Prot# 156-10-292: An Observational Prospective Registry to Identify Demographic and Clinical Characteristics of Patients Hosptitalized with Euvolemic and Hypervolemic Hyponatremia and Assess the Comparative Effectiveness of Available Treatments and the Im

Project: Research project

Project Details

StatusFinished
Effective start/end date3/15/11 → 3/15/14

Funding

  • Mapi USA, Inc. (Prot# 156-10-292 // Prot# 156-10-292)
  • Otsuka America Pharmaceutical, Inc. (Prot# 156-10-292 // Prot# 156-10-292)